Is Nano-X Imaging Just a Hype Train?

Photo of author
Written By Elizabeth Monroe

Nano-X Imaging is a company focused on revolutionizing the X-ray technology market with a new type of X-ray device that integrates a cloud component, allowing images to be securely analyzed after being uploaded.

Despite its promising technology, the company has faced significant challenges and has been a high-risk investment.

Credits: DepositPhotos

Revenue and Profitability Struggles

Fundamentally, Nano-X Imaging has struggled to generate substantial revenue. For the year 2023, the company reported revenue of only $9.9 million, up slightly from $8.6 million in 2022.

Most of this revenue came from teleradiology services, with an increase attributed to gaining more contracts and raising rates for existing customers. However, for a company with a market capitalization of $395.3 million, these sales figures are minimal.

On the profitability front, the company’s net loss for 2023 was $60.8 million, an improvement from the $113.2 million loss in 2022. This reduction was primarily due to lower non-cash impairment charges and other cost savings, though operational costs remained high.

Despite some improvements in other profitability metrics, such as EBITDA and adjusted operating cash flow, the company’s financial health remains precarious.

Recent Financial Performance

For the first quarter of 2024, revenue increased modestly to $2.6 million from $2.4 million in the same period the previous year. However, the net loss expanded to $12.2 million, indicating ongoing profitability issues.

Operating cash flow did improve slightly, but the company continues to burn through its cash reserves at an alarming rate.

Market Potential

The broader market for medical X-ray technology is significant, with an estimated value of $14.2 billion in 2022 and projected to grow to $23.9 billion by 2032. Nano-X Imaging aims to capture a portion of this market with its FDA-cleared Nanox.ARC technology and the associated Nanox.CLOUD platform.

The company has made some progress internationally, with installations in Africa, Latin America, and Asia, and partnerships aimed at expanding its market presence.

AI Integration and Partnerships

One of the more exciting aspects of Nano-X Imaging’s technology is its use of AI to enhance imaging capabilities. The company has entered into agreements with Covera Health and Dandelion Health to provide AI-based solutions, which could improve diagnostic accuracy and open new revenue streams.

Challenges and Risks

However, despite these positive developments, the company’s financial performance has not reflected the potential of its technology. Sales growth has been minimal, and the company continues to incur significant losses. Moreover, Nano-X Imaging has a history of setting ambitious targets and failing to meet them.

For example, the company originally aimed to deploy 15,000 Nanox.ARC devices by the end of 2024 but has only installed 13 units in the U.S. so far.

Additionally, the company’s financial position is further strained by the potential for significant shareholder dilution. Nano-X Imaging recently initiated an at-the-market (ATM) offering to raise up to $100 million, which could result in a 20.2% increase in the number of shares outstanding at current prices.

Promising Potential With Real Risks

Credits: DepositPhotos

Given these factors, investors should approach Nano-X Imaging with caution. While the company’s technology is promising and the market potential is significant, its track record of underperformance and ongoing financial challenges suggest that substantial risks remain.

The company’s ability to turn its technological advancements into meaningful revenue and profitability will be crucial for its future prospects.


You should read and understand this disclaimer in its entirety before joining or viewing the website or email/blog list of (the “Publisher”). The information (collectively the “Advertisement”) disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, and/or losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply. To unsubscribe from receiving promotional text messages to your phone sent via an autodialer, using your phone reply to the sender’s phone number with the word STOP or HELP for help.

The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission (the "SEC") at; the Financial Industry Regulatory Authority (the "FINRA") at, and relevant State Securities Administrator website and the OTC Markets website at The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete.

The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial and/or legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete.

By your subscription to our profiles, the viewing of this profile and/or use of our website, you have agreed and acknowledged the terms of our full disclaimer and privacy policy which can be viewed at the following link: and

By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of (1) a client company, (2) the party issuing or preparing the information for the company, or (3) other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated report/release or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink.